Claris Lifesciences announced its quarterly and half yearly un-audited financial results for the quarter and half year ended June 30, 2014 at its board meeting held at its registered office in Ahmedabad.
The net revenues for Q2CY14 and H1CY14 stood at Rs 1,511 million and 2,841 million respectively, the numbers for the same period in the previous year stood at Rs 2,022 million and Rs 3,844 million respectively. The earnings before interest tax depreciation and amortisation (EBITDA) for Q2CY14 and H1CY14 stood at Rs 414 million and Rs 796 million respectively, the numbers for the same period in the previous year stood at Rs 685 million and Rs 1,226 million respectively.
The EBITDA margin for H1CY14 stood at 28 per cent of the net revenues. The profit after tax (PAT) for Q2CY14 and H1CY14 stood at Rs 155 million and Rs 288 million respectively, the numbers for the same period in the previous year stood at Rs 182 million and Rs 336 million respectively. The PAT margin for H1CY14 stood at 10 per cent of the net revenues.
EP News Bureau- Mumbai
- Advertisement -
